Activist investor Starboard Value said Thursday that it intends to use its stake in Bristol-Myers Squibb to oppose the drug-maker's acquisition of Celgene.
Smith argued that Starboard was"surprised" to hear of the proposed acquisition on the heels of what he characterized as poor financial and stock price performance over the last few years.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisitionSynergies almost never end up creating the shareholder value expected. See KHC over last 2 years.
Source: CNBC - 🏆 12. / 72 Read more »
Celgene falls 8 percent after Wellington Management says it opposes Bristol-Myers acquisitionSynergies almost never end up creating the shareholder value expected. See KHC over last 2 years.
Source: CNBC - 🏆 12. / 72 Read more »
Value investor Greenblatt says market in expensive range historically, likes Home Depot, BoeingBut Buffett said stocks were cheap yesterday. So confusing.
Source: CNBC - 🏆 12. / 72 Read more »